EE186 A Comparative Cost Analysis between Dalbavancin, Oritavancin and Delafloxacin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Spain
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.455
https://www.valueinhealthjournal.com/article/S1098-3015(23)03585-4/fulltext
Title :
EE186 A Comparative Cost Analysis between Dalbavancin, Oritavancin and Delafloxacin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Spain
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)03585-4&doi=10.1016/j.jval.2023.09.455
First page :
Section Title :
Open access? :
No
Section Order :
12478